[Antimicrobial activities of clarithromycin against clinical isolates]. 1996

M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
Section of Studies, Tokyo Clinical Research Center.

To examine the antimicrobial activity of clarithromycin (CAM) against strains clinically isolated from outpatients in 1994, minimum inhibitory concentrations (MICs) were determined for CAM and the control drugs. The results were as follows; 1. MIC50 and MIC90 of CAM were similar to those investigated in 1980's against many bacterial species. 2. CAM showed strong antimicrobial activities against beta-lactamase producing Moraxella subgenus Branhamella catarrhalis, Bordetella pertussis, Campylobacter jejuni subsp. jejuni and Peptostreptococcus spp. 3. It appears that resistance to MLs including CAM is increasing among Streptococcus pneumoniae.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D001936 Moraxella catarrhalis Gram-negative aerobic cocci of low virulence that colonize the nasopharynx and occasionally cause MENINGITIS; BACTEREMIA; EMPYEMA; PERICARDITIS; and PNEUMONIA. Branhamella catarrhalis,Mikrokkokus catarrhalis,Moraxella (Branhamella) catarrhalis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D017291 Clarithromycin A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation. 6-O-Methylerythromycin,A-56268,Biaxin,TE-031,A 56268,A56268,TE 031,TE031

Related Publications

M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
September 1997, The Japanese journal of antibiotics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
June 1993, The Japanese journal of antibiotics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
October 1990, The Japanese journal of antibiotics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
July 1997, The Japanese journal of antibiotics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
July 1996, The Japanese journal of antibiotics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
November 1993, Antimicrobial agents and chemotherapy,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
May 1999, Antimicrobial agents and chemotherapy,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
April 2007, Antimicrobial agents and chemotherapy,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
December 1996, The Japanese journal of antibiotics,
M Koguchi, and Y Suzuki, and S Tanaka, and S Fukayama, and R Ishihara, and K Deguchi, and S Oda, and Y Nakane, and T Fukumoto
June 1999, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!